Koss-Olinger Consulting’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$310K Sell
3,574
-140
-4% -$13.4K 0.03% 204
2025
Q4
$357K Sell
3,714
-1,720
-32% -$167K 0.03% 196
2025
Q3
$474K Hold
5,434
0.04% 212
2025
Q2
$474K Sell
5,434
-476
-8% -$40.4K 0.04% 213
2025
Q1
$531K Sell
5,910
-11,849
-67% -$1.06M 0.04% 186
2024
Q4
$1.42M Sell
17,759
-2,833
-14% -$245K 0.12% 81
2024
Q3
$1.85M Sell
20,592
-1,282
-6% -$108K 0.16% 80
2024
Q2
$1.72M Buy
+21,874
New +$1.79M 0.16% 80
2024
Q1
Sell
-22,969
Closed -$1.89M 204
2023
Q4
$1.89M Sell
22,969
-299
-1% -$22.8K 0.19% 56
2023
Q3
$1.82M Buy
23,268
+192
+0.8% +$16.1K 0.27% 49
2023
Q2
$2.03M Buy
23,076
+267
+1% +$23K 0.24% 45
2023
Q1
$1.84M Buy
22,809
+1,537
+7% +$125K 0.23% 47
2022
Q4
$1.65M Buy
21,272
+14,483
+213% +$1.17M 0.24% 42
2022
Q3
$548K Buy
+6,789
New +$610K 0.09% 93
2022
Q2
Sell
-2,833
Closed -$314K 201
2022
Q1
$314K Buy
2,833
+424
+18% +$44.8K 0.05% 149
2021
Q4
$249K Sell
2,409
-647
-21% -$74.9K 0.04% 167
2021
Q3
$383K Buy
3,056
+1,296
+74% +$168K 0.06% 146
2021
Q2
$218K Buy
+1,760
New +$221K 0.03% 215

Other funds holding MDT

Koss-Olinger Consulting's MDT Position: Q1 2026 in Review

Koss-Olinger Consulting reduced its Medtronic (MDT) stake by 3.8% in Q1 2026, selling an estimated $13.4K and leaving 3,574 shares worth $310K. The position accounts for 0.03% of the portfolio, ranked #204.

Koss-Olinger Consulting first reported a position in MDT in Q2 2021 and has held it in 18 quarters since. The position peaked at $2.03M in Q2 2023. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Koss-Olinger Consulting held 3,574 shares of Medtronic worth $310K as of Q1 2026.
  • Koss-Olinger Consulting sold 140 Medtronic shares in Q1 2026, an estimated $13.4K.
  • Medtronic made up 0.03% of Koss-Olinger Consulting's portfolio in Q1 2026, its #204 holding.
  • Koss-Olinger Consulting first reported a position in Medtronic in Q2 2021 and has held it in 18 quarters since.
  • Koss-Olinger Consulting's Medtronic position peaked at $2.03M in Q2 2023.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Koss-Olinger Consulting's 13F filing for Q1 2026, filed 7 May 2026.